Related Experiment Videos
Monitoring renal allograft rejection with duplex sonography
N J London1, M I Aldoori, J A Bates
1University Department of Surgery, St. James's University Hospital, Leeds, U.K.
Clinical Transplantation
|October 1, 1992
Summary
Renal transplant recipients with a high resistive index (RI) on day 2 post-transplant may experience rejection needing further treatment. Early detection using RI can guide anti-rejection therapy decisions.
Area of Science:
- Nephrology
- Transplant Surgery
- Medical Imaging
Background:
- Early detection of renal allograft rejection is crucial for graft survival.
- Duplex Doppler ultrasound provides non-invasive assessment of renal allograft hemodynamics.
- Resistive index (RI) is a key Doppler parameter reflecting intrarenal arterial resistance.
Purpose of the Study:
- To evaluate the utility of serial duplex Doppler ultrasound measurements of resistive index (RI) in predicting early renal allograft rejection.
- To determine if RI values can differentiate between grafts requiring single versus multiple anti-rejection treatments.
Main Methods:
- Serial duplex Doppler ultrasound studies were performed on 36 renal allograft recipients.
- Reproducibility of RI measurements was assessed.
- RI values were analyzed in relation to rejection episodes and treatment response.
Main Results:
- Grafts experiencing rejection within 3 weeks showed greater RI increases from day 2 to day 5 post-transplant.
- Patients with persistent rejection had significantly higher RI values on diagnosis day and day 2 post-transplant compared to those with single-course treatment.
- An RI > 70 on day 2 post-transplant predicted rejection requiring additional treatment with 100% sensitivity and 80% specificity.
Conclusions:
- Serial RI measurements are valuable for early detection of renal allograft rejection.
- Elevated RI on day 2 post-transplant is a strong predictor of rejection requiring intensified therapy.
- These findings suggest potential for earlier or alternative anti-rejection strategies in high-risk patients.